Dr. Tina Cheng joined the Division of Medical Oncology in 2003, specializing in Cutaneous and Genitourinary Oncology. She is an Associate Professor with the Cumming School of Medicine at the University of Calgary. Dr. Cheng completed medical school in Beijing, followed by an MSc in Molecular Oncology and Medical Oncology residency training at the University of Calgary. As a national expert in Immuno-Oncology, she has published extensive peer-reviewed research on predictors for treatment efficacy and durable survival. Beyond her clinical and research work, Dr. Cheng is a leading advocate for public education on the dangers of indoor tanning. She has published significant research on the association between indoor tanning and early-onset melanoma, including the study of potential underlying molecular pathways. In addition to patient care, she serves as a dedicated mentor to many physicians in the field of Immuno-Oncology.
Cheng, Tina
Medical Oncology
Professor Emerita
MD, FRCP(C)
Web Presence:
Biography
Area of Focus
Dr. Cheng subspecializes in cutaneous and genitourinary malignancies and maintains a highly productive profile in clinical and translational research.
Summary of Research
Dr. Tina Cheng is recognized as a national expert in Immuno-Oncology and a productive clinical trialist. She has led two multicenter clinical trials in Canada and has contributed to two key oncology drug developments in melanoma and prostate cancer. Her current research interests focus on the advancement of Immuno-Oncology for cutaneous and genitourinary malignancies.
Area Of Focus
Dr. Cheng subspecializes in cutaneous and genitourinary malignancies and maintains a highly productive profile in clinical and translational research.
Summary Of Research
Dr. Tina Cheng is recognized as a national expert in Immuno-Oncology and a productive clinical trialist. She has led two multicenter clinical trials in Canada and has contributed to two key oncology drug developments in melanoma and prostate cancer. Her current research interests focus on the advancement of Immuno-Oncology for cutaneous and genitourinary malignancies.